Novartis India Ltd.
|Pantoprazole Sodium Sesquihydrate||40 mg|
Click on the API name to know their properties
|Composit uses/ indication of PANTOZA-CT :|
Gastrointestinal disorders associated with motility disturbances such as gastroesophageal reflux disease, non-ulcer dyspepsia and delayed gastric emptying.
Duodenal ulcer. Gastric ulcer. Reflux oesophagitis, Prophylaxis of NSAID associated peptic ulcer, Zollinger-ellison syndrome and other hypersecretory states.
|Composit contra indication of PANTOZA-CT :|
Hypersensitivity to any component of product.
|Composit side effects of PANTOZA-CT :|
Angioedema, Gynacomastia, Angioedema. Drowsiness, Confusion, Extrapyramidal effects, Diarrhea, Extra pyramidal symptoms.
Weakness, Dizziness, Nausea, Vomiting, Anxiety, Dyspnea, Pain, Pharyngitis, Cough, Arthralgia, Rhinitis, Chest pain, Bronchitis, Backache, Urinary frequency, UTI, Hyperlipidemia, Migraine, Neck pain, Rectal disorders, Hypertonia, Sinusitis, Flu like syndrome, Hyperglycemia.
|Composit caution of PANTOZA-CT :|
Elderly, increase in gastrointestinal motility, gastrointestinal hemorrhage, mechanical obstruction or perforation. dyskinesia. driving and using machines. alcoholics
Long-term therapy may lead to bacterial overgrowth in the GI tract. Hepatic impairment, monitor liver function regularly (if enzymes increase, discontinue), not recommended in children <18 yr, long term use may lead to atrophic gastritis.
Ranbaxy Laboratories Limited